• Home
  • Print this page
  • Email this page
Home About us Editorial board Ahead of print Current issue Search Archives Submit article Instructions Subscribe Contacts Login 
REVIEW
Year : 2018  |  Volume : 4  |  Issue : 2  |  Page : 54-58

The contribution of hexokinase 2 in glioma


1 Department of Experimental Surgery, The Second Affiliated Hospital, Air Force Medical University, Xi'an, Shaanxi, China
2 Department of Neurosurgery, University of Massachusetts Medical School, Worcester, WA, USA
3 Department of Neurosurgery, Brigham and Women's Hospital, Boston, MA, USA

Correspondence Address:
Dr. Yanyang Tu
Department of Experimental Surgery, The Second Affiliated Hospital, Air Force Medical University, Xi'an 710038, Shaanxi
China
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/ctm.ctm_11_18

Rights and Permissions

Glioma is the most frequent malignant neoplasm of the central nervous system with high recurrence and extremely poor prognosis. Hexokinase 2 (HK2) is the key enzyme in Warburg effect that has been proved to promote tumorigenesis and is found highly expressed in several tumors. However, the HK2 function in glioma was reported only in a few studies. In this review, we will summarize the changes in the energy metabolism in glioma and the critical function of HK2 in the process. Further, the recent research progress and perspective of HK2 in the diagnosis and treatment of glioma will be discussed.


[FULL TEXT] [PDF]*
Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed382    
    Printed40    
    Emailed0    
    PDF Downloaded107    
    Comments [Add]    

Recommend this journal